Pre-Market Stock Futures:
The futures are trading lower as we begin the final trading week of 2025, albeit a holiday-shortened one once again. The major indices all finished the session modestly lower on Friday, with the venerable S&P 500 taking early bows as it hit a fresh all-time high, joining the Dow Jones Industrial Average and the Nasdaq, which recently entered all-time high territory. With just two full trading days left in the year, you can expect some volatility this week as investors and traders make final portfolio adjustments to close out the year. With sellers sneaking in late Friday, the Dow Jones Industrial closed at 48,710, down 0.04%, while the aforementioned S&P 500 backed off its intra-day all-time high print to close at 6.929 down 0.03%. The Nasdaq finished the day at 21,593, down 0.09%.
Treasury Bonds:
Yields were flat to moderately lower on Friday as portfolio shuffling and some light profit-taking seemed to be the order for the day. The strong GDP data have challenged expectations for aggressive interest rate cuts next year, supporting a more hawkish stance among some Fed officials. Market pricing currently implies up to two rate cuts in 2026, while the median policymaker projection points to only one. Goldman Sachs said in the fall that it expects two more 25-basis-point reductions in 2026. The 30-year long bond closed Friday at 4.82% while the benchmark 10-year note was last seen at 4.13%.
Oil and Gas:
Both major oil benchmarks closed lower on Friday, with analysts pointing to the usual thin post-holiday trading as concerns about a looming global supply glut outweigh geopolitical supply risks, despite recent disruptions from actions against Venezuela and the ongoing Ukraine conflict. Brent Crude closed the day at $60.87, down 2.2%, while West Texas Intermediate finished Friday’s session at $56.94, down 2.2%. The big winner on Friday was Natural Gas, which had taken a beating over the previous two weeks, as it surged 3.5% higher to close at $4.39. Analysts cited cold weather, high LNG exports, and tighter storage levels, which are expected to drive winter demand upward despite warmer spells. Plus, short covering after a 20%+ move down was a possible reason for the gains.
Gold:
Gold continued to race higher after smashing through the $4500 mark earlier in the week, to finish Friday at $4,494. More positive coverage at Goldman Sachs, which sees the precious metal hitting $4,900 in 2026 and says “Gold remains our single favorite long commodity,” was a factor in Friday’s move higher. Silver also continued on a moonshot parabolic move, closing Friday at $75.98. Both remain at all-time highs, and investors could see additional substantial gains as we head into 2026.
Crypto:
The crypto market saw another day of high volatility and generally mixed to lower trading on Friday, with major assets like Bitcoin initially rising modestly before sliding later in the day due to the typical thin holiday liquidity and a surge in precious metals pricing that drew significant investor capital in end-of-year moves. At 8 a.m. EST on Monday, Bitcoin was quoted at $87,580, while Ethereum was seen at $2,962.
24/7 Wall St. reviews dozens of analyst research reports daily to identify new investment ideas for both investors and traders. Some of these daily analyst calls cover stocks to buy. Other calls cover stocks to sell or avoid. Remember that no single analyst call should ever be used as a basis to buy or sell a stock.
Here are some of the top Wall Street analyst upgrades, downgrades, and initiations seen on Monday, December 29, 2025.
Upgrades:
Downgrades:
- Amicus TherapeuticsInc. (NASDAQ: FOLD) was downgraded to Market Perform from Outperform, lowering the target price to $14.50 from $17 following BioMarin Pharmaceutical Inc.’s recently announced acquisition. (NASDAQ: BMRN)
Initiations:
- Fathom Holdings Inc. (NASDAQ: FTHM) was assumed with a Buy rating at Roth Capital with a $2.50 target price.
- Palisade Bio Inc. (NASDAQ: PALI) was initiated with an Overweight rating at Piper Sandler with a huge $25 target price.
- Turn Therapeutics Inc. (NASDAQ: TTRX) D. Boral Capital initiated the stock with a Buy rating and has an $8 target price.
Reiterations and Price Target Changes:
- Doximity Inc. (NYSE: DOCS) Raymond James reiterated its Strong Buy rating on the stock with a $65 target price following positive meetings with the CEO.
- Intuitive Machines Inc. (NASDAQ: LUNR) Clear Street raised the target price on the shares to $25 from $17 while maintaining a Buy rating on the company.
- KB Home (NYSE: KBH) was reiterated with a Neutral rating at JPMorgan, which cut the target price on the shares to $50 from $71.
- NVIDIA Corp. (NASDAQ: NVDA | NVDA Price Prediction) Truist Securities reiterated a Buy rating on the stock with a $275 target price, noting the recent agreement with Groq as a huge positive despite the high price.
- Okta Inc. (NASDAQ: OKTA) Stephens reiterates a Neutral rating on the stock with a $97 target price.
- On Holdings AG (NYSE: ONON), UBS reiterated a Buy rating on the shares with an $85 target price while remaining very bullish on the company’s prospects.
- Planet Labs PBC (NYSE: PL) Clear Street reiterated a Buy rating on the shares while lifting the target price to $22 from $16.
- Praxis Precision Medicines Inc. (NASDAQ: PRAX) saw its target price raised to $843 from $507 at BTIG, which reiterated a Buy rating on the stock and named it a top pick for 2026.
- Take-Two Interactive Software Inc. (NASDAQ: TTWO) was named a top 2026 idea at Benchmark, which has a Buy rating and a $300 target price objective.
- Vail Resorts Inc. (NYSE: MTN) Truist Securities cut the target price on the stock to $234 from $237 while maintaining a Buy rating on the shares.
Top Gaining Stocks
Top Losing Stocks